These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11987699)

  • 1. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
    Łuczywek E; Pffefer A; Nowicka A; Czyzewski K; ŁaŁowski M; Styczyńska M; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits and polymorphism of apolipoprotein E in Alzheimer's disease.
    Luczywek E; Nowicka A; Pfeffer A; Czyzewski K; Styczyńska M; Lałowski M; Barcikowska M
    Dement Geriatr Cogn Disord; 2002; 13(3):171-7. PubMed ID: 11893839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
    Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
    Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphism and Alzheimer's disease.
    Yen YC; Liu CK; Lung FW; Chong MY
    Kaohsiung J Med Sci; 2001 Apr; 17(4):190-7. PubMed ID: 11482130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
    Lasser RA; Dukoff R; Levy J; Levin R; Lehtimäki T; Seubert P; Sunderland T
    Int J Geriatr Psychiatry; 1998 Nov; 13(11):767-74. PubMed ID: 9850873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease.
    Finton MJ; Lucas JA; Rippeth JD; Bohac DL; Smith GE; Ivnik RJ; Petersen RC; Graff-Radford NR
    J Int Neuropsychol Soc; 2003 Jul; 9(5):751-9. PubMed ID: 12901781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High apolipoprotein E epsilon 4 allele frequency in age-related memory decline.
    Blesa R; Adroer R; Santacruz P; Ascaso C; Tolosa E; Oliva R
    Ann Neurol; 1996 Apr; 39(4):548-51. PubMed ID: 8619535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.